The Therapy of the rebel severe Psoriazis with Biological Preparats

Abstract

Biological therapy consists of the use of substances that are a top medical technology and research, which are based on clinical trials on thousands of patients, proofing their efficacy and safety. The study was conducted on 18 patients diagnosed with severe psoriasis who have not responded to conventional treatments. Eleven patients received adalimumab 80 mg in the first week, then 40 mg every two weeks throughout and 7 patients received etanercept at a dose of 50 mg/week. Conclusion: Both adalimumab and etanercept an effective therapeutic alternatives for the treatment of rebel severe psoriasis.